Zenglei Han
Qingdao, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Advances in Nanotechnology for Lymphoma Treatment: Targeted Delivery, Immunomodulation, and TME-Responsive Therapy Strategies.
Journal: International journal of nanomedicine
Published: December 10, 2025
The C-reactive protein-triglyceride-glucose index predicts new-onset atrial fibrillation after ST-segment elevation myocardial infarction.
Journal: Frontiers in cardiovascular medicine
Published: October 30, 2025
Development and application of a predictive model for survival and drug therapy based on COVID-19-related lncRNAs in non-small cell lung cancer.
Journal: Medicine
Published: December 10, 2024
Correlation between chromatin epigenetic-related lncRNA signature (CELncSig) and prognosis, immune microenvironment, and immunotherapy in non-small cell lung cancer.
Journal: PloS one
Published: March 20, 2023
Correlation Analysis Among the Level of IL-35, Microvessel Density, Lymphatic Vessel Density, and Prognosis in Non-Small Cell Lung Cancer.
Journal: Clinical and translational science
Published: November 15, 2019
Reciprocal regulation of miR-206 and IL-6/STAT3 pathway mediates IL6-induced gefitinib resistance in EGFR-mutant lung cancer cells.
Journal: Journal of cellular and molecular medicine
Published: May 13, 2019
Clinical significance of FAP-α on microvessel and lymphatic vessel density in lung squamous cell carcinoma.
Journal: Journal of clinical pathology
Published: October 25, 2017
Co-expression of pregnane X receptor and ATP-binding cassette sub-family B member 1 in peripheral blood: A prospective indicator for drug resistance prediction in non-small cell lung cancer.
Journal: Oncology letters
Published: January 13, 2015
Showing 1-8 of 8
Last Updated: 09/26/2026